Skip to main content

NIH Working Group

This is the trans-NIH Working Group that oversees the development, implementation, communication, and assessment of the NIH Common Fund program.

Co-Chairs:

Co-Chairs are Institute or Center (IC) directors or IC senior staff who lead the Working Group and have the authority to approve major activities and funding actions.

  • Joni L. Rutter, Ph.D.
    Director
    National Center for Advancing Translational Sciences (NCATS)
  • Dinah S. Singer, Ph.D.
    Deputy Director
    National Cancer Institute (NCI)

Leadership Team & Points of Contact:

Coordinators, Program Leaders, and Project Team Leaders serve as the day-to-day leadership for the program and the Working Group. Also included here are points of contact for areas of program management.

Working Group Coordinators:

  • T. Kevin Howcroft, Ph.D.
    Program Director
    Division of Cancer Biology
    Cancer Immunology and Hematology Branch
    National Cancer Institute (NCI)
  • Danilo A. Tagle, Ph.D.
    Associate Director for Special Initiatives
    National Center for Advancing Translational Sciences (NCATS)

Common Fund Program Leader:

  • Patricia (Trish) Labosky, Ph.D.
    Program Leader
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
    National Institutes of Health (NIH)

Points of Contact:

  • Angela Ambrosi, M.P.A.
    Business Operations and Analysis Contact
    Program/Management Analyst
    Office of Strategic Coordination
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
  • Sara Amolegbe, M.S.P.H
    Strategic Planning, Evaluation, and Communications Contact
    Health Science Policy Analyst
    Office of Strategic Coordination
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
  • Christine Happel, Ph.D.
    Program Officer
    National Center for Advancing Translational Sciences (NCATS)

Members:

The Working Group Members are staff from multiple NIH Institutes and Centers who provide input from their Institute or Center’s perspective.

  • Alexandra Ainsztein, Ph.D.
    Program Director
    Division of Cell Biology and Biophysics
    National Institute of General Medical Sciences (NIGMS)
  • Preethi Chander, Ph.D.
    Program Director
    Salivary Biology and Immunology Program
    National Institute of Dental and Craniofacial Research (NIDCR)
  • Aniruddha Ganguly, Ph.D.
    Program Director
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis
    National Cancer Institute (NCI)
  • Daniel Gossett, Ph.D.
    Program Director
    Division of Kidney, Urologic, and Hematologic Diseases
    National Institute of Diabetes and Digestive and Kidney Diseases
  • Max Guo, Ph.D.
    Chief, Genetics and Cell Biology Branch
    Division of Aging Biology
    National Institute on Aging (NIA)
  • Nic Johnston, M.S.
    Scientific Program Analyst
    National Institute on Drug Abuse (NIDA)
  • Lillian S. Kuo, Ph.D.
    Program Director
    Division of Cancer Biology
    National Cancer Institute (NCI)
  • Tania B. Lombo, Ph.D.
    Program Officer
    Environmental Influences on Child Health Outcomes (ECHO)
    Office of the Director (OD)
    National Institutes of Health (NIH)
  • George A. McKie, D.V.M., Ph.D.
    Program Director
    Ocular Infection, Inflammation, and Immunology
    National Eye Institute (NEI)
  • Margaret Ochocinska, Ph.D.
    Program Director
    Translational Blood Science and Resources Branch
    Division of Blood Diseases and Resources
    National Heart, Lung, and Blood Institute (NHLBI)
  • Daniel Shaughnessy, Ph.D.
    Health Science Administrator
    Exposure, Response, and Technology Branch
    Division of Extramural Research and Training 
    National Institute of Environmental Health Sciences (NIEHS)
  • Dobrila (Doda) Rudnicki, Ph.D.
    Program Officer
    National Center for Advancing Translational Science (NCATS)
  • Anna Sadusky, Ph.D.
    Program Officer
    Division of Kidney, Urologic and Hematologic Diseases (KUH)
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • John Satterlee, Ph.D.
    Program Director
    Epigenetics, Model Organism Genetics, Functional Genomics
    National Institute on Drug Abuse (NIDA)
  • Shurjo K. Sen, Ph.D.
    Program Director
    Division of Genome Sciences
    National Human Genome Research Institute (NHGRI)
  • Jessica Smith, Ph.D.
    Scientific Review Officer
    Cell Biology Integrated Review Group
    Center for Scientific Review (CSR)
  • Pothur R. Srinivas, Ph.D., M.P.H.
    Program Director
    Division of Cardiovascular Sciences
    National Heart, Lung, and Blood Institute (NHLBI)

This page last reviewed on December 3, 2024